Diphenhydramine for nausea and vomiting related to cancer chemotherapy with cisplatin
- 1 November 1991
- journal article
- clinical trial
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 6 (8) , 461-465
- https://doi.org/10.1016/0885-3924(91)90001-k
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Antiemetic Efficacy of Droperidol or Metoclopramide Combined with Dexamethasone and DiphenhydramineOncology, 1991
- The Antiemetic Activity of High-Dose Metoclopramide and High-Dose Alizapride in Combination with Lorazepam in Patients Receiving Cancer ChemotherapyOncology, 1991
- Metoclopramide versus metoclopramide and lorazepam. Superiority of combined therapy in the control of cisplatin-induced emesisCancer, 1989
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- Antiemetic efficacy of high-dose dexamethasone: Randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramineBritish Journal of Cancer, 1988
- The Management of Chemotherapy-Induced Nausea and VomitingMedical Clinics of North America, 1987
- Improved control of cisplatin-induced emesis with high-dose metoclopramide and with combinations of metoclopramide, dexamethasone, and diphenhydramine. Results of consecutive trials in 255 patientsCancer, 1985
- The Assessment of Nausea and VomitingCancer, 1984
- Intravenous MetoclopramideJAMA, 1982
- MetoclopramideNew England Journal of Medicine, 1981